Jio in a Fundraising Mode, Gets investment 4th & 5th ones from GA & KKR

Mukesh Ambani is unstoppable to bring one after another investment for his dream project, Jio to 'further propel Jio's vision of enabling a digital society for India'. In a month Jio Platforms fetched a hopping total of 78,562 crore rupees of investment from different American companies including social giant Facebook. 

Investment from Facebook, SilverLake and Vista Equity has already been published on my earlier post. Recent investments in Jio would be coming from General Atlantic Partners and KKR ＆ Co. Both companies are headquartered in New York.

General Atlantic is one of the early investor in Uber and Airbnb. Definitely they are looking towards change in India's digital ecosystem. 

Airtel is Concentrating into Betterment of Networks & Enterprise Business

As Jio is getting invested from overseas, to be debt-free and being financially prepared for 5G, Bharti Airtel is not standing idle, they are investing on networks as well as future networks. For Airtel 4G expansion and being 5G ready is crucial, as Airtel is all set to phase out 3G. As their 4G network is not omnipresence, they can't shut down 2G services anytime soon.

So Airtel has to increase 4G footprint, significantly in rural areas. Also in urban areas their capacity to handle wireless data is to be increased multifold in the time of Covid-19 due to lockdown as people are working from home.

Jio is Getting More Investments from America

Amidst lockdown India's richest man and his son, Mukesh Ambani and Akash Ambani is busy with their video conferences as they are drawing investment from overseas one after another. 

On April 21, 2020 Facebook announced Rs 43,574 crore investment into Jio Platforms, and in two weeks Jio got two more investments from America. 

Institutes & Pharma Co Running a Race to Deliver COVID-19 Vaccine

Elisa Granato, Molecular Microbiologist of University of Oxford
was the first volunteer in the Oxford vaccine trial for COVID-19

As I joined my medical career in 2007, there was a different drug practice, and now it has changed a lot. My pharma textbook had mere 10 sentences on carbapenems but they became ubiquitous in present critical care units. For last 5 years (atleast) I saw a good number of drugs being approved by FDA, many of them are monoclonal antibodies (mab) for autoimmune diseases or for cancer treatment. I am not sure about their efficacy but I know these are not cheap! 

However as 2020 saw a pandemic of COVID-19 by beta coronavirus, I can see a race to deliver potential vaccine candidate to humankind is already started by educational institutes as well as pharma companies.